Stryker is a medical technologies company. The Company operates through three business segments: Orthopedics, Medical and Surgical (MedSurg), and Neurotechnology and Spine. Orthopedics products consist primarily of implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; and reprocessed and remanufactured medical devices as well as other medical device products used in a variety of medical specialties. Stryker Neurotechnology and Spine products include a portfolio of products including both neurosurgical and neurovascular devices. The Company's neurotechnology offering includes products used for minimally invasive endovascular techniques, as well as a line of products for traditional brain and open skull base surgical procedures, orthobiologic and biosurgery products including synthetic bone grafts and vertebral augmentation products, as well as minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Stryker also develops, manufactures and markets spinal implant products including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

Company Growth (employees)
Type
Public
HQ
Kalamazoo, US
Founded
1946
Size (employees)
33,000 (est)
Stryker was founded in 1946 and is headquartered in Kalamazoo, US

Key People/Management at Stryker

Michael Hutchinson

Michael Hutchinson

General Counsel
Bijoy Sagar

Bijoy Sagar

Vice President, Chief Information Officer
Yin Becker

Yin Becker

Vice President, Communications and Public Affairs
Dean Bergy

Dean Bergy

Vice President, Corporate Secretary
William Berry

William Berry

Vice President, Corporate Controller
Jeanne Blondia

Jeanne Blondia

Vice President, Finance and Treasurer
Glenn Boehnlein

Glenn Boehnlein

Vice President, Chief Financial Officer
Lonny Carpenter

Lonny Carpenter

Group President, Global Quality and Business Operations
Irene Corbe

Irene Corbe

Vice President, Internal Audit
William Cymbaluk

William Cymbaluk

Vice President, Corporate Regulatory Affairs and Quality Assurance
M. Fink

M. Fink

Vice President, Chief Human Resources Officer
David Floyd

David Floyd

Group President, Orthopaedics
David Furgason

David Furgason

Vice President, Tax
Graham McLean

Graham McLean

President, Asia Pacific
Katherine Owen

Katherine Owen

Vice President, Strategy and Investor Relations
Timothy Scannell

Timothy Scannell

Group President, MedSurg and Neurotechnology
Bronwen Taylor

Bronwen Taylor

Vice President, Compliance and Risk Management

Stryker Office Locations

Stryker has offices in Kalamazoo, Singapore, Hong Kong, Ontario and in 291 other locations
Kalamazoo, US (HQ)
2825 Airview Boulevard
Sydney, AU
8 Herbert Street St Leonards
Ontario, CA
45 Innovation Drive Hamilton
Hong Kong, HK
Suites 1101-1103, Oxford House Taikoo Place, 979 King's Road
Tokyo, JP
Sumitomo Fudosan Iidabashi First Tower 29F/30F 2-6-1 Koraku, Bunkyo-ku
Amsterdam, NL
Herikerbergweg 110
Show all (295)

Stryker Financials and Metrics

Stryker Financials

Stryker's revenue was reported to be $11.3 b in FY, 2016
USD

Revenue (Q3, 2017)

3 b

Gross profit (Q3, 2017)

2 b

Gross profit margin (Q3, 2017), %

66%

Net income (Q3, 2017)

434 m

EBIT (Q3, 2017)

523 m

Market capitalization (16-Feb-2018)

60.8 b

Cash (30-Sep-2017)

2.6 b
Stryker's current market capitalization is $60.8 b.
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

9 b9.7 b9.9 b11.3 b

Revenue growth, %

7%3%14%

Cost of goods sold

2.8 b3 b3.3 b3.3 b3.8 b

Gross profit

6 b6.4 b6.6 b7.5 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

2.2 b2.3 b2.4 b2.4 b2.4 b2.4 b2.4 b2.5 b2.8 b2.8 b3 b3 b3 b

Cost of goods sold

682 m769 m808 m822 m826 m827 m796 m801 m998 m960 m993 m1 b1 b

Gross profit

1.5 b1.5 b1.6 b1.6 b1.6 b1.6 b1.6 b1.7 b1.8 b1.9 b2 b2 b2 b

Gross profit Margin, %

68%67%66%66%65%66%67%68%65%66%66%66%66%
USDY, 2011Y, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

905 m1.4 b1.3 b1.8 b3.4 b3.3 b

Inventories

535 m524 m564 m480 m

Current Assets

8.3 b9.7 b7.9 b7.9 b

Goodwill

3.8 b4.2 b4.1 b6.4 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

1.1 b1.4 b1.3 b1.4 b1.7 b3.6 b3.2 b7 b3.5 b3 b3.2 b3.6 b2.6 b

Accounts Receivable

72 m

Inventories

210 m231 m254 m257 m260 m270 m296 m325 m363 m396 m476 m495 m602 m

Current Assets

9.2 b8.4 b9.4 b9.3 b8.7 b8.9 b8 b11.3 b7.8 b7.4 b7.9 b8.5 b7.7 b
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    1 b515 m1.4 b1.6 b

    Accounts Receivable

    (89 m)(89 m)(151 m)(192 m)

    Inventories

    (77 m)(173 m)(115 m)(299 m)

    Accounts Payable

    1 m13 m35 m(16 m)
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Net Income

    103 m70 m128 m57 m224 m616 m917 m402 m782 m1.1 b444 m835 m434 m

    Depreciation and Amortization

    42 m46 m94 m97 m94 m188 m289 m102 m247 m395 m150 m310 m473 m

    Accounts Receivable

    57 m93 m(40 m)(65 m)12 m39 m26 m86 m57 m22 m112 m97 m72 m

    Inventories

    (43 m)(61 m)(59 m)(97 m)(42 m)(67 m)(124 m)(109 m)(225 m)(307 m)(114 m)(192 m)602 m
      USDY, 2017

      Revenue/Employee

      91.1 k

      Financial Leverage

      2.1 x
      Show all financial metrics

      Stryker Operating Metrics

      FY, 2014FY, 2015FY, 2016

      Patents (foreign)

      3.4 k3.01 k3.45 k

      Patents (US)

      1.9 k1.88 k2.18 k
      Show all operating metrics

      Stryker Market Value History

      Stryker Median Salaries

      Source: 220 public H-1B filings from Stryker

      Stryker's Web-traffic and Trends

      Stryker News and Updates

      Sports Medicine Market 2018; Promises a Striking Fortune of USD 9.6 Million by 2023

      The Global Sports Medicine Market SWOT Analysis, Key Development Areas, Financial Overview of the Sports Medicine industry report predicted to reach $ 9,655.6 million by the end of 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

      Sports Medicine Products 2018 Global Market Key Players -Arthrex, Smith & Nephew, Depuy Synthes Companies, Stryker, Conmed -Analysis And Forecast To 2025

      Wiseguyreports.Com Adds “Sports Medicine Products – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

      Knee Implants United States Market by Trends & Outlook with vendors B. Braun, Smith & Nephew, Zimmer Biomet Holding Inc., Stryker

      HTF MI presents an in-depth assessment of current Knee Implants key market drivers, market size and trends and United States Knee Implants opportunities, challenges, and restraints as well as key market segments, technological updates, impact of any regulatory policies as well as key market segments…

      Americas Suture Needles Market Flourishes Relentlessly; Asserts MRFR Unleashing Industry Forecast Up To 2023

      Market research future has a half cooked research report on Suture Needles market. The Suture Needles market is growing rapidly by 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

      Genu Recurvatum Market Value Share 4.5% | Top Key Player Analysis | Forecast to 2023

      Genu Recurvatum Market based on Various Factors Such As Price Analysis, Supply Chain Analysis, Porters Five Force Analysis Etc. Posted via Industry Today. Follow us on Twitter @IndustryToday

      Artificial Joints 2018 Global Market Net Worth $ 18120 million USD Forecast By 2021

      WiseGuyReports.Com Publish a New Market Research Report On –“ Artificial Joints 2018 Global Market Net Worth $ 18120 million USD Forecast By 2021”. Posted via Industry Today. Follow us on Twitter @IndustryToday
      Show more

      Stryker Company Life and Culture

      You may also be interested in